Since transfer of central memory T cells provided superior anti-tumor effect compared to effector memory or effector T cells, (Gattinoni et al., 2005; Klebanoff et al., 2005), pharmacological modulation to promote the differentiation of central memory CD8 T cells during in vitro expansion would greatly improve the efficacy of immunotherapy. This evidence concerns the gene CD8A and neoplasm.